Skip to main content

Table 5 Multivariate analysis of significant clinical, pathological, and immunohistochemical features influencing the DFS and OS in 85 patients with malignant GISTs of the small intestine who underwent curative resection

From: Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate

Variable

Relative risk

95% CI for relative risk

P value

DFS

Tumor size (2–5, 5–10, and >10 cm)

  

NS

Local invasion

  

NS

Tumor perforation

  

NS

Mitotic count >5 per 50 HPF

11.36

2.653–50.0

0.001

High cellularity

2.004

1.036–3.876

0.039

Tumor necrosis

  

NS

Ki-67 index

3.460

1.1.195

0.049

OS

Tumor size (2–5, 5–10, and >10 cm)

  

NS

Tumor perforation

3.058

1.20–7.81

0.019

Mitotic count >5 per 50 HPF

6.711

1.50–30.30

0.013

High cellularity

2.370

1.11–5.08

0.026

Tumor necrosis

  

NS

Vascular proliferation

  

NS

Lymphatic infilatration

  

NS

Ki-67 index 10%

  

NS

  1. DFS = disease-free survival; OS = overall survival; GISTs = gastrointestinal stromal tumors; CI = confidence interval